ZNF426 Antibody

What is ZNF426 and what are its known biological functions?

ZNF426 (Zinc Finger Protein 426) is a transcription factor belonging to the zinc finger protein family mapped to chromosome 19p13.2 in humans . It functions primarily as a transcriptional regulator, containing zinc finger domains that enable DNA binding activity . The protein has a calculated molecular weight of approximately 63.1 kDa . While its specific biological functions are still being investigated, ZNF426, like other zinc finger proteins, is likely involved in diverse cellular processes including cell differentiation, transcriptional regulation, cell metabolism, and potentially immune response mechanisms . The protein is predominantly localized to the nucleus, consistent with its role in transcriptional regulation .

What applications are ZNF426 antibodies validated for in research?

ZNF426 antibodies have been validated for several research applications:

• Western Blotting (WB): Typically using dilutions of 1:1000 to 2.5 μg/mL

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Immunohistochemistry (IHC): Recommended dilutions of 1:50-1:200

• Immunofluorescence (IF): Using concentrations of 0.25-2 μg/mL

• Immunocytochemistry (ICC)

• Chromatin Immunoprecipitation (ChIP)

Different antibodies may be optimized for specific applications, so researchers should select antibodies based on their validated applications rather than assuming universal functionality .

What tissue and species reactivity should researchers consider when selecting ZNF426 antibodies?

Most commercially available ZNF426 antibodies are reactive to human ZNF426 . Some antibodies also show cross-reactivity with:

• Non-human primates (monkey, chimpanzee, gorilla, marmoset)

• Rodents (mouse, rat) with varying degrees of homology (approximately 85%)

When selecting an antibody, researchers should:

• Verify the species reactivity in the product documentation

• Consider the percent identity by BLAST analysis (e.g., human 100%, mouse/rat 85%)

• For immunohistochemistry studies, review available tissue staining data from resources like the Human Protein Atlas

How should ZNF426 antibodies be properly stored and handled?

Proper storage and handling of ZNF426 antibodies are critical for maintaining their functionality:

• Most ZNF426 antibodies should be stored at -20°C for long-term preservation

• For short-term storage (less than 1 week), 4°C is acceptable

• Avoid repeated freeze-thaw cycles as they can degrade antibody quality

• For long-term storage at -20°C, using 50% glycerol is recommended

• Antibodies shipped in lyophilized form should be reconstituted according to manufacturer instructions, typically using PBS buffer with 2% sucrose

• Aliquoting antibodies into smaller volumes for single-use is recommended to prevent degradation from multiple freeze-thaw cycles

What are the optimal protocols for Western blotting using ZNF426 antibodies?

For optimal Western blotting with ZNF426 antibodies:

Sample Preparation:

• Use human cell lysates (particularly cell lines with known ZNF426 expression)

• Include appropriate positive controls (such as human tissue lysates)

• Load 20-50 μg of total protein per lane

Protocol Optimization:

• Primary antibody concentration: Use at recommended dilutions (typically 1:1000 or 2.5 μg/mL)

• Incubation: Overnight at 4°C is typically recommended for best results

• Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Detection: Use secondary antibodies appropriate for your primary antibody (typically anti-rabbit IgG for most ZNF426 antibodies)

• Expected band: Approximately 63.1 kDa, but verify with each antibody's documentation

Validation Controls:

• Include a negative control (secondary antibody only)

• Consider including a blocking peptide competition control to verify specificity

• When possible, compare results with multiple ZNF426 antibodies targeting different epitopes

What are the recommended protocols for immunohistochemistry with ZNF426 antibodies?

For immunohistochemistry using ZNF426 antibodies:

Tissue Preparation:

• Formalin-fixed, paraffin-embedded (FFPE) tissues are commonly used

• Antigen retrieval is typically necessary (heat-induced epitope retrieval in citrate buffer pH 6.0)

• Section thickness: 4-5 μm is standard for most applications

Staining Protocol:

• Dilution range: 1:50-1:200 is typically recommended for IHC applications

• Incubation time: 1-2 hours at room temperature or overnight at 4°C

• Detection system: Use appropriate secondary antibody and visualization system compatible with your primary antibody

• Counterstain: Hematoxylin is commonly used to visualize tissue architecture

Controls and Validation:

• Include positive control tissues (consult antibody documentation for recommended positive controls)

• Include negative controls (omit primary antibody)

• For critical studies, confirm findings using antibodies targeting different epitopes

How can researchers optimize immunofluorescence studies with ZNF426 antibodies?

For immunofluorescence using ZNF426 antibodies:

Sample Preparation:

• Cell fixation: 4% paraformaldehyde for 15-20 minutes at room temperature

• Permeabilization: 0.1-0.2% Triton X-100 for 5-10 minutes

• Blocking: 1-5% BSA or normal serum (matching the host of secondary antibody)

Staining Protocol:

• Antibody concentration: 0.25-2 μg/mL is recommended for IF applications

• Incubation: 1-2 hours at room temperature or overnight at 4°C

• Secondary antibody: Use fluorophore-conjugated antibodies appropriate for your imaging system

• Nuclear counterstain: DAPI or Hoechst is recommended to visualize nuclei

Expected Localization:

• ZNF426 typically shows nuclear localization, consistent with its function as a transcription factor

• Some cytoplasmic staining may also be observed depending on cell type and antibody specificity

How does ZNF426 expression relate to cancer and disease states?

Recent research has begun to investigate ZNF426 in disease contexts:

Expression in Cancer:

• Studies have examined ZNF426 expression in head and neck squamous cell carcinomas (HNSCC)

• ZNF426 was included in a panel of zinc finger proteins evaluated for potential biomarker status in HNSCC

• Differential expression between normal and cancer tissues has been observed, suggesting potential diagnostic value

Correlation with Clinical Parameters:

Research Approaches:

• When investigating ZNF426 in cancer contexts, researchers should:

  • Compare expression between normal and tumor tissues

  • Correlate expression with clinical parameters and outcomes

  • Consider analyzing publicly available datasets (TCGA, GEO) for broader context

What experimental strategies should be employed to investigate ZNF426's role in transcriptional regulation?

To investigate ZNF426's role in transcriptional regulation:

Target Gene Identification:

• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to identify genomic binding sites of ZNF426

• RNA-seq after ZNF426 knockdown or overexpression to identify genes regulated by ZNF426

• Motif analysis to identify consensus DNA binding sequences recognized by ZNF426

Functional Studies:

• Gene activation or knockout studies using CRISPR/Cas9 technology

• The synergistic activation mediator (SAM) transcription activation system can be used to study ZNF426 function

• Reporter gene assays to assess the effect of ZNF426 on promoter activity

Protein Interaction Studies:

• Co-immunoprecipitation followed by mass spectrometry to identify protein interaction partners

• Yeast two-hybrid screening for protein-protein interaction analysis

• Proximity ligation assays to confirm interactions in cellular contexts

How can researchers validate the specificity of ZNF426 antibodies for their specific applications?

Validating ZNF426 antibody specificity is critical for reliable research:

Recommended Validation Approaches:

• Western blot analysis showing a band of expected molecular weight (approximately 63.1 kDa)

• Signal reduction following siRNA/shRNA knockdown of ZNF426

• Overexpression studies showing increased signal intensity

• Pre-absorption with immunizing peptide to demonstrate signal reduction

• Comparison of staining patterns across multiple antibodies targeting different epitopes of ZNF426

Application-Specific Validation:

• For IHC/IF: Compare staining patterns with published data from resources like the Human Protein Atlas

• For WB: Verify single band of correct molecular weight and reduction after knockdown

• For ChIP: Include IgG control and validate enrichment at predicted binding sites

Documentation:

• Researchers should document all validation steps performed

• Include validation data in publications

• Report antibody catalog numbers, lot numbers, and dilutions used

What is the relationship between ZNF426 and other zinc finger proteins in cellular function?

Understanding ZNF426 in the broader context of zinc finger proteins:

Functional Classification:

• ZNF426 belongs to the C2H2 zinc finger protein family, the largest class of transcription factors in humans

• Like other ZNFs, it likely functions in transcriptional regulation through DNA binding

Comparative Analysis:

• ZNF426 shares structural similarities with other C2H2 zinc finger proteins

• Phylogenetic analysis can reveal evolutionary relationships with other ZNFs

• Functional studies suggest that while ZNFs have diverse roles, many are involved in:

  • Transcriptional regulation

  • Immune responses

  • Cell cycle control

  • Metabolism regulation

Research Approaches:

• When studying ZNF426 in relation to other ZNFs, researchers should:

  • Perform comparative expression analysis across tissues

  • Investigate potential redundant or complementary functions

  • Consider co-expression networks of multiple ZNFs

  • Analyze functional domains and compare with other family members

What controls should be included when using ZNF426 antibodies in research studies?

Proper controls are essential for reliable research with ZNF426 antibodies:

Essential Controls for All Applications:

• Negative controls: Omit primary antibody but include all other reagents

• Isotype controls: Use non-specific IgG from the same species as the primary antibody

• Positive controls: Include samples known to express ZNF426

Application-Specific Controls:

• For Western blotting:

  • Molecular weight markers

  • Loading controls (β-actin, GAPDH, etc.)

  • Lysates from cells with ZNF426 knockdown or overexpression

• For IHC/IF:

  • Tissue/cells known to express ZNF426

  • Absorption controls using immunizing peptide

  • Secondary antibody-only controls

• For ChIP:

  • Input DNA (pre-immunoprecipitation)

  • IgG control immunoprecipitation

  • Positive control regions (known transcription factor binding sites)

How should researchers address inconsistent results when using different ZNF426 antibodies?

When faced with inconsistent results from different ZNF426 antibodies:

Systematic Troubleshooting Approach:

What methodological approaches can help distinguish ZNF426 from other highly similar zinc finger proteins?

Distinguishing ZNF426 from similar ZFPs requires careful methodological considerations:

Antibody Selection:

• Choose antibodies raised against unique regions of ZNF426 that have low homology with other ZFPs

• Review cross-reactivity data provided by manufacturers

• When possible, use antibodies that have been tested against protein arrays to confirm specificity

Experimental Approaches:

• Use genetic approaches (siRNA, CRISPR) targeting ZNF426-specific sequences

• Perform peptide competition assays with ZNF426-specific peptides

• Consider using mass spectrometry for definitive protein identification

Data Analysis:

• Examine expected molecular weight carefully (ZNF426 is approximately 63.1 kDa)

• For RNA-based methods, design primers in regions with lowest homology to related ZFPs

• When analyzing public datasets, assess probe or primer specificity for possible cross-hybridization

How can researchers integrate ZNF426 findings with broader zinc finger protein research in cancer studies?

Integrating ZNF426 research into the broader ZFP cancer context:

Data Integration Approaches:

• Perform meta-analyses combining ZNF426 data with other ZFP studies in cancer

• Use bioinformatic approaches to identify common pathways regulated by different ZFPs

• Develop network analyses to visualize relationships between ZNF426 and other cancer-associated ZFPs

Comparative Analysis Frameworks:

• Compare expression patterns of multiple ZFPs across cancer types and stages

• Analyze correlation patterns between ZNF426 and other ZFPs in public datasets (TCGA, GEO)

• Examine common target genes or signaling pathways affected by different ZFPs

Study Design Considerations:

• When studying ZNF426 in cancer:

  • Include other relevant ZFPs as comparators

  • Assess potential redundancy or compensation mechanisms

  • Consider analyzing multiple ZFPs simultaneously to identify synergistic effects

  • Correlate findings with immune infiltration and stromal scores

Table 1: Recommended Validation Methods for ZNF426 Antibodies by Application

How is ZNF426 being investigated in the context of head and neck squamous cell carcinomas?

Recent research has examined ZNF426 in head and neck squamous cell carcinomas (HNSCC):

Key Research Findings:

• ZNF426 has been included in a panel of zinc finger proteins evaluated for differential expression in HNSCC

• Studies have examined ZNF426 expression in different anatomical locations within HNSCC (oral cavity, pharynx, larynx)

• Expression differences between normal and tumor tissues have been quantified

• ROC curve analysis has been used to assess ZNF426's potential as a diagnostic biomarker

Relationship with Clinical Parameters:

• Research has investigated correlations between ZNF426 expression and:

  • HPV status in HNSCC patients

  • Patient survival outcomes

  • Cancer molecular subtypes

  • Immune cell infiltration patterns

Methodological Approaches:

• TCGA data analysis has been employed to examine ZNF426 expression patterns

• Statistical approaches like Kaplan-Meier survival analysis have been used to assess prognostic value

• Multi-gene signatures including ZNF426 have been developed and evaluated

What techniques are being used to study ZNF426's role in transcriptional regulation networks?

Contemporary research employs several advanced techniques to investigate ZNF426's role in transcriptional networks:

Genomic Approaches:

• ChIP-seq to identify genome-wide binding patterns of ZNF426

• ATAC-seq to assess chromatin accessibility at ZNF426 binding sites

• CUT&RUN for high-resolution mapping of ZNF426 binding sites

Transcriptomic Approaches:

• RNA-seq after ZNF426 modulation to identify regulated genes

• GRO-seq to assess immediate transcriptional changes

• scRNA-seq to examine cell-type specific effects

Functional Genomics:

• CRISPR activation/inhibition systems to modulate ZNF426 expression

• Synergistic activation mediator (SAM) systems for transcriptional activation

• Massively parallel reporter assays to assess regulatory potential

Computational Approaches:

• Motif analysis to identify DNA binding preferences

• Network analysis to place ZNF426 in broader regulatory contexts

• Machine learning to predict ZNF426 targets and functions

How can researchers assess ZNF426's involvement in immune response mechanisms?

Investigating ZNF426's potential role in immune responses requires specialized approaches:

Experimental Strategies:

• Compare ZNF426 expression across immune cell populations (flow cytometry, single-cell RNA-seq)

• Assess changes in ZNF426 expression after immune stimulation (cytokines, TLR ligands)

• Analyze immune-related pathways after ZNF426 modulation

Relevant Research Context:

• Several zinc finger proteins play roles in immune response regulation, immune homeostasis, and cytokine production

• ZFPs like Gfi1, ZFP36, ZFYVE1 have established roles in inflammatory responses and innate immunity

• CCCH zinc finger proteins form regulatory networks maintaining immune homeostasis

Analysis Frameworks:

• Correlation analysis between ZNF426 expression and immune cell infiltration

• Pathway analysis focusing on immune-related gene sets

• Cytokine profiling after ZNF426 modulation in relevant cell types

Table 2: Comparison of ZNF426 with Other Functionally Characterized Zinc Finger Proteins

How does ZNF426 expression correlate with tumor immune microenvironment characteristics?

Recent studies have begun exploring relationships between zinc finger proteins and tumor immune microenvironments:

Research Approaches:

• Analysis of ZNF426 expression in relation to immune cell infiltration patterns

• Correlation of ZNF426 with stromal and immune scores in tumor samples

• Assessment of relationships between ZNF426 and immune checkpoint molecules

Relevant Findings:

• Some zinc finger proteins show correlation with specific immune cell populations in tumors

• ZNF-based gene signatures have been associated with differences in:

  • T cell infiltration

  • B cell presence

  • Macrophage polarization

  • Cytolytic activity scores

  • Inflammatory responses

  • Checkpoint molecule expression

Methodological Considerations:

• Researchers investigating ZNF426 in this context should:

  • Use computational deconvolution methods to estimate immune cell fractions

  • Correlate ZNF426 expression with established immune signature scores

  • Validate findings using multiplexed immunohistochemistry or flow cytometry